SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-013502
Filing Date
2017-03-27
Accepted
2017-03-27 19:11:38
Documents
2
Period of Report
2017-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3989
2 EXHIBIT 24.1 - POWER OF ATTORNEY poa_unkart.htm EX-24.1 5695
  Complete submission text file 0001140361-17-013502.txt   11360
Mailing Address 6 VALLEY OAK PORTOLA VALLEY CA 94028
Business Address
Unkart Edward W (Reporting) CIK: 0001306267 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 17716471

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations